WHO to List Exchange Programs in Cancer Ed

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 9
Volume 7
Issue 9

ROCHESTER, NY--The WHO International Network for Cancer Education (INCE) is putting together a list of exchange programs in cancer education, (eg, exchange of students, residents, or faculty), involving a European or US center and a corresponding center in Asia, Africa, or Latin America.

ROCHESTER, NY--The WHO International Network for Cancer Education (INCE) is putting together a list of exchange programs in cancer education, (eg, exchange of students, residents, or faculty), involving a European or US center and a corresponding center in Asia, Africa, or Latin America.

The INCE is sponsoring a symposium on such exchange programs on November 4-7, 1998, in Portland, Oregon, and is soliciting descriptions of such activities, comments, and ideas for future use, as well as abstracts of papers.

Physicians or institutions may contact Charles D. Sherman, Jr, MD, Highland Hospital, 1000 South Avenue, Rochester, NY 14620.

Articles in this issue
Intensive Effort Required to Develop a Breast Cancer Risk Assessment Clinic
NCI Readies Its Cancer Genetics Network for Collaborative Studies
Payer Relationships Key to Transplant Revenues
Taking Family Cancer History May Release Emotions
Ovarian Cortical Tissue Is Cryopreserved for Future Fertility
Advice Offered for Daughters of Women With Breast Cancer
WHO to List Exchange Programs in Cancer Ed
Women’s Groups Ask Congress for Global Tobacco Controls
Brain Tumor Patients Urged to ‘Seize Control’ of Their Seizures
UCSF Breaks Ground for Its New Clinical Cancer Building
Preventive Effects of Tamoxifen Vary With HER2 Level
NIH Expert Dispels Myths About Genetic Counseling
Advanced Colorectal Cancer Patients May Prefer Raltitrexed
FDG-PET Finds Residual, Recurrent Hodgkin's Disease
Ceprate Gets FDA Nod for Peripheral Blood Stem Cell Selection

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.
2 experts in this video
2 experts in this video
Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.
Increasing the use of patient-reported outcomes may ensure that practitioners can fully ascertain the impact of treatment for rare lymphomas.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
Related Content
Chemoradiotherapy resulted in lower incidence of local progression, prompting an evaluation of resectability in patients with advanced gallbladder cancers.

Chemoradiation Prolongs OS, Maintains QOL in Advanced Gallbladder Cancers

Roman Fabbricatore
April 24th 2025
Article

Chemoradiotherapy resulted in lower incidence of local progression, prompting an evaluation of resectability in patients with advanced gallbladder cancers.

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
April 21st 2025
Podcast

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Large B-Cell Lymphoma

Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Large B-Cell Lymphoma

American Society for Transplantation and Cellular Therapy
April 24th 2025
Article

In a multicenter retrospective study authors examined the impact of prior inotuzumab ozogamicin exposure on the outcomes of brexu-cel therapy in adults with R/R B-cell ALL.

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Cristiane Decat Bergerot, PhD
April 14th 2025
Podcast

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies

Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies

American Society for Transplantation and Cellular Therapy
April 24th 2025
Article

Researchers conducted a comprehensive review on how intrinsic T cell characteristics influence CAR-T cell therapy outcomes in hematological malignancies.

FDA Clears IND for VS-7375 in KRAS 612D-Mutated Advanced Solid Tumors

FDA Clears IND for VS-7375 in KRAS 612D-Mutated Advanced Solid Tumors

Tim Cortese
April 24th 2025
Article

The clearance precedes the initiation of a phase 1/2a trial that will evaluate the efficacy and safety of VS-7375 in advanced solid tumors with a KRAS-612D mutation.